Variables | Group D (N = 18) | Group ND (N = 25) | P-values |
---|---|---|---|
Age, years | 42.5 (1–68) | 38.74y (2–64) | 0.348 |
Male | 14 (77.78 %) | 16 (64 %) | |
Underlying diseases* | 18 (100 %) | 0 | |
Diabetes | 6 (33.33 %) | 0 | |
Lymphoma | 1 (5.56 %) | 0 | |
β-thalassemia | 2 (11.11 %) | 0 | |
Breast cancer | 1 (5.56 %) | 0 | |
Previous glucocorticoid therapy | 1 (5.56 %) | 0 | |
Langerhans cell histiocytosis | 1 (5.56 %) | 0 | |
G-6PD deficiency | 1 (5.56 %) | 0 | |
Systemic lupus erythematosus | 1 (5.56 %) | 0 | |
Subacute thyroiditis | 1 (5.56 %) | 0 | |
Chronic hepatitis B | 2 (11.11 %) | 0 | |
Hyperthyroidism | 2 (11.11 %) | 0 |